Risperidone versus placebo for schizophrenia.
Rattehalli
Ranganath D
RD
North Yorkshire and York NHS Trust, York, UK. rdrattehalli@hotmail.com
Jayaram
Mahesh B
MB
Smith
Michael
M
D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010054:Brief Psychiatric Rating Scale; D006801:Humans; D008609:Mental Status Schedule; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D016032:Randomized Controlled Trials as Topic; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D018967:Risperidone